Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$6,349,782
+$1,178,836 QoQ
Shares Held
5,294
-5.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.92%
of 13F equity value
Holder Rank
#1,534
of 4,605 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Accent Capital Management, LLC holds $7,805,317 across 7 Drug Manufacturers - General names. LLY ranks #1 (81.4% of the industry book) .
All Filings in LLY
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,349,782 | 5,294 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $5,170,946 | 5,622 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $6,145,020 | 5,718 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $4,436,082 | 5,814 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,479,958 | 5,747 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $4,801,014 | 5,813 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $4,543,992 | 5,886 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,945,524 | 2,196 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $2,703,464 | 2,986 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,313,653 | 2,974 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,633,924 | 2,803 | Shares | Sole | 2024-03-19 | |
| No filing history on record for this holder in this stock. | ||||||